June 2016 DMID Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Find a Funding Opportunity.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

In Vitro Assessments for Antimicrobial Activity

Request for Proposals—proposed FY 2018 initiative

Contact: Tiffany Chadwick

Objective: To provide a variety of in vitro screening services to the research community to assess antimicrobial activity (antiviral, antibacterial, antifungal, antimycobacterial, and/or antiparasitic) of new or existing compounds.

Description: These contracts will provide screening for antimicrobial activity against a variety of pathogens, including newly emerged, highly pathogenic, and/or drug-resistant strains. Most often the in vitro screening service is the first step requested by product developers with potential therapeutics. Specifically, a compound is initially tested in vitro against a broad bacterial, fungal, or viral in vitro panel. This broad in vitro testing is an efficient way to screen large numbers of compounds. For many compounds it is a way to indicate, at an early stage for a relatively modest cost, whether a compound has promise. For those compounds showing promise, secondary, in vitro screens allow further exploration of clinical potential.

Nonclinical Services for the Development of Interventional Agents for Infectious Diseases

For the published request for proposals, see the March 29, 2017 solicitation, Nonclinical Services for Development of Interventional Agents for Infectious Diseases.

Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases

For the published request for proposals, see the May 15, 2017 solicitation, Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases.

Manufacturing and Characterization for Vaccines and Other Biologics for Infectious Diseases

For the published request for proposals, see the March 10, 2017 solicitation, Manufacturing and Characterization Services for Vaccines and Other Biologics for Infectious Diseases.

Systems Biology: The Next Generation for Infectious Diseases

For the published request for applications, see the November 16, 2016 Guide announcement, Systems Biology: The Next Generation for Infectious Diseases (U19).

International Research in Infectious Diseases, Including AIDS

For the published program announcement, with special receipt, referral, and/or review considerations, see the January 27, 2017 Guide announcement International Research in Infectious Diseases, Including AIDS (R01).

Content last reviewed on May 16, 2017